J Faintuch
About
In The Last Decade
J Faintuch
22 papers receiving 470 citations
Peers
Comparison fields: 5 of 68
- Oncology 322
- Surgery 115
- Pathology and Forensic Medicine 106
- Pulmonary and Respiratory Medicine 99
- Hepatology 90
Countries citing papers authored by J Faintuch
This map shows the geographic impact of J Faintuch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Faintuch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Faintuch more than expected).
Fields of papers citing papers by J Faintuch
This network shows the impact of papers produced by J Faintuch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Faintuch. The network helps show where J Faintuch may publish in the future.
Co-authorship network of co-authors of J Faintuch
This figure shows the co-authorship network connecting the top 25 collaborators of J Faintuch. A scholar is included among the top collaborators of J Faintuch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Faintuch. J Faintuch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 29 | |
| 2 | [The prognostic value of cholesterol levels in malnourished patients with esophageal carcinoma]. | 1 |
| 3 | 46 | |
| 4 | 8 | |
| 5 | 121 | |
| 6 | 12 | |
| 7 | A phase II trial of recombinant human interferon-gamma and recombinant tumor necrosis factor in patients with advanced gastrointestinal malignancies: results of a trial terminated by excessive toxicity. | 16 |
| 8 | 3 | |
| 9 | [Traumatic injuries of the colon: primary suture or colostomy?]. | 2 |
| 10 | Phase I and II studies of the combination of recombinant human interferon-gamma and 5-fluorouracil in patients with advanced colorectal carcinoma. | 14 |
| 11 | Phase I trial of recombinant human gamma-interferon and recombinant human tumor necrosis factor in patients with advanced gastrointestinal cancer. | 58 |
| 12 | 9 | |
| 13 | 43 | |
| 14 | 2 | |
| 15 | 8 | |
| 16 | Treatment of metastatic colorectal carcinoma with cisplatin and 5-FU. | 10 |
| 17 | 8 | |
| 18 | 71 | |
| 19 | [Clinico-surgical repercussions of cholecystocolic fistula]. | 1 |
| 20 | [Recent progress of nutrition in surgery]. | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.